Clinical Trial Update: Pioglitazone as a Treatment for Lipid and Glucose Abnormalities In Patients With Schizophrenia [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating pioglitazone for lipid and glucose abnormalities in patients with schizophrenia has completed, with results posted in Decemb…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment
• Diabetes Mellitus
• Insulin Resistance
• Schizophrenia

Drugs mentioned

• Actos (Pioglitazone)

Snippet

Sponsor: Nathan Kline Institute for Psychiatric Research | Conditions: Diabetes, Schizophrenia | Phase 4 | Status: COMPLETED | Results posted: 2017-12-11